Agreement builds on previous Novartis success using emerging technologies to develop first-in-class gene therapies for neurological disorders
The large-scale production of PhytoChol in Hanau, Germany, will meet an increased market demand for cholesterol
Robust pipeline with around 50 projects in clinical development / cardiology portfolio poised for growth with launch products Kerendia (finerenone) and Verquvo (vericiguat)
More than 2,500 submissions are currently under review in the Food and Drug Administration's (FDA) cell and gene therapy pipeline
Collaboration aims to evolve precision medicine with cell-specific delivery of gene therapy
Newly formed Life Science Services business unit to offer fully integrated CDMO and Contract Testing Services
Despite the challenges of pandemic disruptions, drug developers advance promising therapies for conditions, including Alzheimer's, diabetes and asthma
Under the terms of the agreement, Mammoth Biosciences will receive an upfront payment of USD 40 million, potential future payments of more than one billion USD upon successful achievement of certain research, development, and commercial milestones
PeproTech's recombinant proteins portfolio complements Thermo Fisher's cell culture media products
The investment in Yapan Bio allows Piramal Pharma Solutions to broaden its service offerings in the fast-growing biologics CDMO space
Subscribe To Our Newsletter & Stay Updated
